Cancer immunology and immunotherapy.
作者信息
Ren Xiubao
机构信息
Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
出版信息
Cancer Biol Med. 2021 Nov 24;18(4):931-3. doi: 10.20892/j.issn.2095-3941.2021.0036.
Abstract
摘要
相似文献
1
Cancer immunology and immunotherapy.
Cancer Biol Med. 2021 Nov 24;18(4):931-3. doi: 10.20892/j.issn.2095-3941.2021.0036.
2
The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy.
Cancer Cell. 2022 Jul 11;40(7):701-702. doi: 10.1016/j.ccell.2022.05.016. Epub 2022 Jun 16.
3
Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.
Cancer Immunol Res. 2020 Jan;8(1):3-6. doi: 10.1158/2326-6066.CIR-19-0888.
4
Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?
Ann Oncol. 2021 Nov;32(11):1311-1313. doi: 10.1016/j.annonc.2021.09.010. Epub 2021 Sep 21.
5
What's new in surgical oncology: impact of immunology and tumour biology.
J R Coll Surg Edinb. 1990 Dec;35(6):341-4.
6
Tumor immunology.
Immunol Ser. 1990;50:513-33.
7
Bispecific antibodies in cancer immunotherapy.
Hum Vaccin Immunother. 2016 Oct 2;12(10):2491-2500. doi: 10.1080/21645515.2016.1187802. Epub 2016 Jun 1.
8
Cancer immunotherapies targeting the PD-1 signaling pathway.
J Biomed Sci. 2017 Apr 4;24(1):26. doi: 10.1186/s12929-017-0329-9.
9
Cancer immunotherapy comes of age.
Nature. 2011 Dec 21;480(7378):480-9. doi: 10.1038/nature10673.
10
Editorial: Decoding immunologic complex systems in cancer: the cutting-edge technologies revolutionizing cancer immunology and immunotherapy.
Front Immunol. 2023 May 4;14:1208589. doi: 10.3389/fimmu.2023.1208589. eCollection 2023.
引用本文的文献
1
The Role of the TIMP1/LINC01615 Axis as a Regulator of the EMT Pathway in Gastric Cancer.
Biol Proced Online. 2025 Aug 18;27(1):31. doi: 10.1186/s12575-025-00297-y.
2
Comprehensive analysis reveals CLDN9 is a new biomarker in human cancers and immunotherapeutic target for glioblastoma multiforme.
Cancer Cell Int. 2025 Jun 18;25(1):216. doi: 10.1186/s12935-025-03852-5.
3
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.
Lipids Health Dis. 2025 Jan 31;24(1):31. doi: 10.1186/s12944-024-02429-x.
4
The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors.
Front Immunol. 2023 Oct 24;14:1284334. doi: 10.3389/fimmu.2023.1284334. eCollection 2023.
5
Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors.
Cancer Biol Med. 2023 Nov 6;20(11):856-68. doi: 10.20892/j.issn.2095-3941.2023.0281.
6
First-line tremelimumab plus durvalumab and chemotherapy chemotherapy alone for metastatic non-small cell lung cancer: a cost-effectiveness analysis in the United States.
Front Pharmacol. 2023 Jul 20;14:1163381. doi: 10.3389/fphar.2023.1163381. eCollection 2023.
7
Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio.
Medicina (Kaunas). 2023 Jul 11;59(7):1285. doi: 10.3390/medicina59071285.
8
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer.
Breast Cancer Res Treat. 2023 Oct;201(3):515-533. doi: 10.1007/s10549-023-07032-9. Epub 2023 Jul 17.
9
Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.
Adv Sci (Weinh). 2023 Jul;10(21):e2300878. doi: 10.1002/advs.202300878. Epub 2023 May 10.
10
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies.
Cancer Biol Med. 2022 Jul 21;19(7):948-64. doi: 10.20892/j.issn.2095-3941.2022.0049.
本文引用的文献
1
Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357.
Signal Transduct Target Ther. 2020 Oct 19;5(1):244. doi: 10.1038/s41392-020-00337-x.
2
A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
3
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
4
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors.
J Immunother Cancer. 2019 Nov 15;7(1):306. doi: 10.1186/s40425-019-0805-8.
Zotero 插件